Company / Total Assets
Vivos Therapeutics, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$25.2M
FY2025
5-year range
$13.7M / $33.7M
FY2021-FY2025
Trend
+64.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $14M to $25M over the past 2 years.
Based on SEC 10-K filings.
$25M in FY2025 with a 5-year CAGR of -0.1%.
Improved from $14M to $25M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +22.4%
- 5-Year CAGR
- -0.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.1%, indicating a declining trend.
- In FY2025, total assets increased 64.6% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.2M | +64.6% |
| FY2024 | $15.3M | +11.4% |
| FY2023 | $13.7M | +0.0% |
| FY2022 | $13.7M | -59.3% |
| FY2021 | $33.7M | +33.0% |
| FY2020 | $25.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026